Skip to Content

CK19-01a

Main Content

Outcomes after hematopoietic cell transplants for rare chronic leukemias: Evaluating outcomes of allogeneic hematopoietic cell transplantation in T-cell prolymphocytic leukemias

Study #: CK19-01a

Study Status: Published

Presentation(s)

2020, ASH (Oral)

Outcomes of allogeneic hematopoietic cell transplantation in T cell prolymphocytic leukemia: A contemporary analysis from the Center for International Blood and Marrow Transplant Research.

Citation

Murthy HS, Ahn KW, Estrada-Merly N, Alkhateeb HB, Bal S, Kharfan-Dabaja MA, Dholaria B, Foss F, Gowda L, Jagadeesh D, Sauter C, Abid MB, Aljurf M, Awan FT, Bacher U, Badawy SM, Battiwalla M, Bredeson C, Cerny J, Chhabra S, Deol A, Diaz MA, Farhadfar N, Freytes C, Gajewski J, Gandhi MJ, Ganguly S, Grunwald MR, Halter J, Hashmi S, Hildebrandt GC, Inamoto Y, Jimenez-Jimenez AM, Kalaycio M, Kamble R, Krem MM, Lazarus HM, Lazaryan A, Maakaron J, Munshi PN, Munker R, Nazha A, Nishihori T, Oluwole OO, Ortí G, Pan DC, Patel SS, Pawarode A, Rizzieri D, Saba NS, Savani B, Seo S, Ustun C, van der Poel M, Verdonck LF, Wagner JL, Wirk B, Oran B, Nakamura R, Scott B, Saber W.

Transplantation and Cellular Therapy. 2022, Apr 01: 28(4): 28(4):187.e1-187.e10. doi: 10.1016/j.jtct.2022.01.017. Epub 2022, Jan 23. PMCID:PMC8977261.

PubMed

PMID: 35081472

Abstract